Anu Biswas has extensive work experience in supply chain management and planning. Anu is currently the SVP of Global Supply Chain at ProKidney Corp. Prior to this, they held the position of Head of Supply Chain at CRISPR Therapeutics from 2020 to 2023. Before that, they worked at Celgene as the Head of CAR-T Planning and Operations from 2018 to 2020. Anu also has experience as Senior Director, Head of Supply Chain - North America at Dr. Reddy's Laboratories from 2013 to 2017, and as Director, Head of Materials Management and Logistics at Patheon in 2012. Anu started their career at Price Waterhouse Management Consultants as a Management Consultant in the healthcare sector from 2011 to 2012. Additionally, Anu worked at Auxilium Pharmaceuticals as the Head of Global Planning and Logistics from 2009 to 2011, and as Associate Director, Global Product Planning at Bristol Myers Squibb from 2002 to 2009.
Anu Biswas has an MBA in Operations and Logistics from The Ohio State University Fisher College of Business. Anu also holds a Bachelor of Science degree in Physics and Chemistry from the University of Mumbai. In addition, they have obtained the APICS CSCP certification from APICS.
Org chart
Teams
Offices
This person is not in any offices
ProKidney Corp.
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases potentially drive meaningful improvement in kidney function. Late-stage CKD, Stage 3b - 4, is a key target for REACT™ therapy. REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program, which launched in January 2022. For more information, visit www.prokidney.com.
